Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Day One Biopharmaceuticals, Inc. (DAWN)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 87,040,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Day One Biopharmaceuticals is a clinical-stage biopharmaceutical company. Co. is engaged in developing and commercializing targeted therapies for patients with genomically-defined cancers. Co.'s main product candidate, DAY101 (tovorafenib), is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor. Co.'s second product candidate, pimasertib, is an oral, highly-selective small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2 (MEK), a well-characterized key signaling node in the RAS/mitogen-activated protein kinase pathway.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 2,244,684 4,978,018
Total Buy Value $0 $0 $24,978,318 $65,978,328
Total People Bought 0 0 1 3
Total Buy Transactions 0 0 4 7
Total Shares Sold 225,453 235,538 246,104 4,525,329
Total Sell Value $3,837,225 $3,955,119 $4,100,690 $62,122,635
Total People Sold 4 4 4 8
Total Sell Transactions 14 18 25 103
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 168
  Page 6 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Papanek Julie Director   –       •      –    2022-07-05 4 AS $20.00 $16,000 I/I (800) 463,200     -
   Bender Jeremy Chief Executive Officer   •       •      –    2022-07-01 4 AS $20.00 $34,920 D/D (1,746) 1,263,944     -
   Blackman Samuel C. Chief Medical Officer   •       –      –    2022-07-01 4 AS $18.24 $187,158 D/D (10,000) 1,306,718     -
   York Charles N Ii COO, CFO and Secretary   •       –      –    2022-07-01 4 AS $20.00 $29,580 D/D (1,479) 336,081     -
   Atlas Venture Opportunity Fund I, L.p. 10% Owner   –       –       •   2022-07-01 4 AS $0.00 $0 D/D (198,280) 793,116     -
   Papanek Julie Director   –       •      –    2022-07-01 4 AS $20.00 $20,000 I/I (1,000) 464,000     -
   Gladstone Michael Director   –       •      –    2022-06-17 4 B $15.00 $11,500,005 I/I 766,667 766,667 2.1     -
   Atlas Venture Associates Opportunity I, Llc 10% Owner   –       –       •   2022-06-17 4 B $15.00 $11,500,005 D/D 766,667 766,667 2.45     -
   Blavatnik Len Affiliate of 10% Owner   –       –      –    2022-06-17 4 B $15.00 $18,000,000 D/D 1,200,000 10,684,638 2.44     -
   Blackman Samuel C. Chief Medical Officer   •       –      –    2022-06-15 4 AS $16.26 $813,155 D/D (50,000) 1,316,718     -
   Blavatnik Len Affiliate of 10% Owner   –       –      –    2022-01-20 4 B $14.73 $67,976 D/D 4,615 9,484,638 2.44     -
   Blavatnik Len Affiliate of 10% Owner   –       –      –    2022-01-19 4 B $14.70 $864,566 D/D 58,818 9,480,023 2.44     -
   Blavatnik Len Affiliate of 10% Owner   –       –      –    2022-01-18 4 B $14.26 $619,367 D/D 43,429 9,421,205 2.44     -
   Blackman Samuel C. Chief Medical Officer   •       –      –    2022-01-03 4 AS $16.95 $171,018 D/D (10,000) 1,366,718     -
   Canaan Partners Xi Llc 10% Owner   –       –       •   2021-12-21 4 D $0.00 $0 D/D (536,000) 9,663,645     -
   Canaan Partners Xi Llc 10% Owner   –       –       •   2021-12-08 4 D $0.00 $0 D/D (536,000) 10,199,645     -
   Takeda Ventures, Inc. 10% Owner   –       –       •   2021-12-08 4 S $18.03 $1,989,394 I/I (110,338) 6,120,124     -
   Takeda Ventures, Inc. 10% Owner   –       –       •   2021-12-07 4 S $18.43 $3,507,475 I/I (186,935) 6,230,462     -
   Takeda Ventures, Inc. 10% Owner   –       –       •   2021-12-06 4 S $18.05 $1,763,341 I/I (97,692) 6,417,397     -
   Takeda Ventures, Inc. 10% Owner   –       –       •   2021-12-03 4 S $18.47 $231,189 I/I (12,517) 6,515,089     -
   Blackman Samuel C. Chief Medical Officer   •       –      –    2021-12-01 4 AS $16.62 $172,242 D/D (10,000) 1,376,718     -
   Blackman Samuel C. Chief Medical Officer   •       –      –    2021-10-22 4 GA $0.00 $0 I/I 1,000,000 1,000,000     -
   Blackman Samuel C. Chief Medical Officer   •       –      –    2021-10-22 4 GD $0.00 $0 D/D 1,000,000 1,386,718     -
   Blavatnik Len Affiliate of 10% Owner   –       –      –    2021-06-01 4 B $16.00 $14,000,000 D/D 875,000 9,377,776 2.44     -
   Blavatnik Len Affiliate of 10% Owner   –       –      –    2021-06-01 4 A $0.00 $0 D/D 8,502,776 8,502,776     -
  168 Records found
  1  2  3  4  5  6  7   
  Page 6 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us